Literature DB >> 8969733

Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia.

G Lack1, H D Ochs, E W Gelfand.   

Abstract

OBJECTIVE: To determine primary and secondary antibody responses in children with hypogammaglobulinemia attributed to corticosteroid use.
RESULTS: In seven patients with steroid-dependent asthma and significant hypogammaglobulinemia (IgG concentration, 275 to 443 mg/dl), antibody responses to protein and polysaccharide antigens were shown to be normal, as were primary and secondary responses to a neoantigen, bacteriophage phi X174.
CONCLUSIONS: Patients with asthma, and with hypogammaglobulinemia resulting from steroid therapy, have normal humoral immunity, and immunoglobulin replacement therapy is not indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969733     DOI: 10.1016/s0022-3476(96)70035-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

2.  Common variable immunodeficiency.

Authors:  Jonathan S Tam; John M Routes
Journal:  Am J Rhinol Allergy       Date:  2013 Jul-Aug       Impact factor: 2.467

Review 3.  Key aspects for successful immunoglobulin therapy of primary immunodeficiencies.

Authors:  C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2011-06       Impact factor: 4.330

Review 4.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  Acquired hypogammaglobulinemia and pathogen-specific antibody depletion after solid organ transplantation in human immunodeficiency virus infection: A brief report.

Authors:  Margaret Newman; Kevin Gregg; Randee Estes; Kenneth Pursell; David Pitrak
Journal:  Transpl Infect Dis       Date:  2019-10-14       Impact factor: 2.228

Review 6.  Update on the use of rituximab for intractable rheumatoid arthritis.

Authors:  R John Looney
Journal:  Open Access Rheumatol       Date:  2009-06-26

Review 7.  Phage therapy in allergic disorders?

Authors:  Andrzej Górski; Ewa Jończyk-Matysiak; Marzanna Łusiak-Szelachowska; Ryszard Międzybrodzki; Beata Weber-Dąbrowska; Jan Borysowski
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-23

Review 8.  B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders.

Authors:  Jan Traub; Leila Husseini; Martin S Weber
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-06

9.  Vascular endothelial growth factor receptor inhibitor SU5416 suppresses lymphocyte generation and immune responses in mice by increasing plasma corticosterone.

Authors:  Jamison J Grailer; Douglas A Steeber
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 10.  Treatment strategies for autoimmune encephalitis.

Authors:  Yong-Won Shin; Soon-Tae Lee; Kyung-Il Park; Keun-Hwa Jung; Ki-Young Jung; Sang Kun Lee; Kon Chu
Journal:  Ther Adv Neurol Disord       Date:  2017-08-16       Impact factor: 6.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.